Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Quinoxaline-2-carbaldehyde → 2-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxaline
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Quinoxaline-2-carbaldehyde | HCID 594088 | — |
| 반응물 | Sodium triacetoxyborohydride | HCID 5049666 | — |
| 반응물 | HCID 57678297 | HCID 57678297 | — |
| 촉매 | Acetic Acid | HCID 176 | — |
| 용매 | 1,2-Dichloroethane | HCID 11 | — |
| 생성물 | 2-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxaline | HCID 11998277 | 55% |
반응 단계
The piperazine template (0.075 g, 0.213 mmol) of Example 24 was dissolved in 1,2-dichloroethane (3 mL) and treated with quinoxaline-2-carbaldehyde (0.044 g, 0.277 mmol) and glacial acetic acid (2 drops). Sodium triacetoxyborohydride (0.090 g, 0.426 mmol) was added, and the mixture was stirred at room temperature until the reaction was complete by LCMS analysis. The solvent was removed under reduced pressure, and the resulting residue was purified by RP-HPLC to yield the free base (0.0578 g, 55% yield). MS (ESI) m/z 494.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07531542B2 |
| 출처 데이터셋 | uspto-grants-2009_05 |
| ORD ID | ord-e55cb59139414209ac3587dd58e64a21 |
| 출처 메모 | uspto-grants-2009_05 |